Related references
Note: Only part of the references are listed.Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes
Ling Li et al.
ONCOGENE (2019)
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
S. K. Daniel et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
BTN3A is a prognosis marker and a promising target for V gamma 9V delta 2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
Audrey Benyamine et al.
ONCOIMMUNOLOGY (2018)
Expansion of human T cells for adoptive immunotherapy using a bisphosphonate prodrug
Yoshimasa Tanaka et al.
CANCER SCIENCE (2018)
Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma
Y. Maruse et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2018)
Anti-CD3 Fab Fragments Enhance Tumor Killing by Human γδ T Cells Independent of Nck Recruitment to the γδ T Cell Antigen Receptor
Claudia Juraske et al.
FRONTIERS IN IMMUNOLOGY (2018)
Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia
Gabrielle M. Siegers et al.
FRONTIERS IN IMMUNOLOGY (2018)
New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
Juan-Luis Blazquez et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
Kaitlin Graham et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Expression of hypoxia-induced factor-1 alpha in early-stage and in metastatic oral squamous cell carcinoma
Maisa Ribeiro et al.
TUMOR BIOLOGY (2017)
Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
Tianchi Yu et al.
YONSEI MEDICAL JOURNAL (2017)
Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
David Kung-Chun Chiu et al.
NATURE COMMUNICATIONS (2017)
Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment
Kyun-Do Kim et al.
NATURE COMMUNICATIONS (2017)
Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function
Yael Gropper et al.
CELL REPORTS (2017)
Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage
Elena Lo Presti et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Hypoxia Enhances Immunosuppression by Inhibiting CD4(+) Effector T Cell Function and Promoting Treg Activity
Astrid M. Westendorf et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
Clemence Granier et al.
ESMO OPEN (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF- and miR23a transfer
Guy Berchem et al.
ONCOIMMUNOLOGY (2016)
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
Donnele Daley et al.
CELL (2016)
IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients
Rushikesh Sudam Patil et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells
Chao Niu et al.
BMC IMMUNOLOGY (2015)
Phenotypic switch of CD8+ T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells
Romain Vuillefroy de Silly et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Cutting Edge: Hypoxia-Inducible Factor 1 Negatively Regulates Th1 Function
Hussein Shehade et al.
JOURNAL OF IMMUNOLOGY (2015)
Hypoxia-mediated immune evasion of pancreatic carcinoma cells
Yebin Lu et al.
MOLECULAR MEDICINE REPORTS (2015)
Five layers of receptor signaling in γδ T-cell differentiation and activation
SergioT. Ribeiro et al.
FRONTIERS IN IMMUNOLOGY (2015)
A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells
Daniela Schilling et al.
CELL STRESS & CHAPERONES (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
A fat story-antigen presentation by butyrophilin 3A1 to γδ T cells
Charlotte Esser
CELLULAR & MOLECULAR IMMUNOLOGY (2014)
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
Pin Wu et al.
IMMUNITY (2014)
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
Andrew Sandstrom et al.
IMMUNITY (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Involvement of Notch in Activation and Effector Functions of γδ T cells
Dimpu Gogoi et al.
JOURNAL OF IMMUNOLOGY (2014)
The CD3 Conformational Change in the γδ T Cell Receptor Is Not Triggered by Antigens but Can Be Enforced to Enhance Tumor Killing
Elaine P. Dopfer et al.
CELL REPORTS (2014)
gamma delta T cells for cancer immunotherapy A systematic review of clinical trials
Jonathan P. H. Fisher et al.
ONCOIMMUNOLOGY (2014)
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function
Eoin N. McNamee et al.
IMMUNOLOGIC RESEARCH (2013)
Butyrophilin Btn2a2 Inhibits TCR Activation and Phosphatidylinositol 3-Kinase/Akt Pathway Signaling and Induces Foxp3 Expression in T Lymphocytes
Johannes U. Ammann et al.
JOURNAL OF IMMUNOLOGY (2013)
Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
Subhashis Sarkar et al.
PLOS ONE (2013)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+ Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche
Jaclyn Sceneay et al.
CANCER RESEARCH (2012)
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Yuhui Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Eric V. Dang et al.
CELL (2011)
CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human gamma delta peripheral blood lymphocytes
Ana deBarros et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis
Andrea Maul-Pavicic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Low-strength T-cell activation promotes Th17 responses
Harriet A. Purvis et al.
BLOOD (2010)
Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis
Daiko Wakita et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
A Butyrophilin Family Member Critically Inhibits T Cell Activation
Tomohide Yamazaki et al.
JOURNAL OF IMMUNOLOGY (2010)
Induction of HIF-1α and the glycolytic pathway alters apoptotic and differentiation profiles of activated human T cells
Anis Larbi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis
Muhammad Zaeem Noman et al.
JOURNAL OF IMMUNOLOGY (2009)
Thymic selection determines γδ T cell effector fate:: Antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon γ
Kirk D. C. Jensen et al.
IMMUNITY (2008)
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome
Sydney M. Evans et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells:: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens
Craig T. Morita et al.
IMMUNOLOGICAL REVIEWS (2007)
Homing and function of human skin γδ T cells and NK cells:: Relevance for tumor surveillance
Lisa M. Ebert et al.
JOURNAL OF IMMUNOLOGY (2006)
Hypoxia inducible factor 1α regulates T cell receptor signal transduction
AK Neumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hypoxia modulates early events in T cell receptor-mediated activation in human T lymphocytes via Kv1.3 channels
JR Robbins et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)